HEOR News Roundup

Tuesday, October 1, 2019 | Issue 471

Subscribe Contact Advertise HEOR & RWE Marketplace

Sponsored by

Report Finds U.S. Pays Significantly More
for Drugs Than Other Countries

A report from the House Ways & Means Committee suggests that U.S. patients pay, on average, about four times more for some drugs than 11 similarly-developed countries.

Read More

Leonard Outlines Proposed Changes to ICER Framework

Pharmspective’s Espinoza Discusses New HealthPlanView

Hamrick: More Informed Patients Can Have Better Outcomes

States Pushing Forward with Efforts to Boost Price Transparency




Internal Audit and Third-Party Risk

October 2-4 | Philadelphia, Pennsylvania




New Approaches for Fast Impact: Using Real World Data for a Successful Commercialization Strategy

October 1

Syndicated Reports
Benchmarking Key Account Management Capabilities (2019)
The Future of Key Account Management in Pharma
White Papers
The Link Between Drug Prices and Research on the Next Generation of Cures
Social Determinants of Health: The Impact on Members, Health Outcomes and the Bottom Line
  Communications Manager Senior/Principal Health Economist Senior Statistician - Modeling & Simulation - London, UK Lead Statistician - Modeling & Simulation - Flexible Location  

Share this newsletter!